v3.22.2.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash $ 56,785 $ 77,258
Accounts receivable 31 200
Prepaid expenses, deposits, and other current assets 5,163 5,179
Total current assets 61,979 82,637
Fixed assets, net 2,374 1,585
Operating lease right-of-use assets 3,079
Intangible assets, net 3,950 2,029
Other assets 1,083 725
Total assets 72,465 86,976
Current liabilities:    
Accounts payable 2,454 3,299
Accrued expenses and other current liabilities 2,930 4,259
Operating lease liabilities, current portion 1,027
Senior Secured Convertible Notes - at fair value 35,500
Total current liabilities 41,911 7,558
Operating lease liabilities, less current portion 1,998
Total liabilities 43,909 7,558
Commitments and contingencies (Note 9)
Stockholders’ Equity:    
Preferred stock, $0.001 par value. Authorized, 20,000,000 shares; Series B Convertible Preferred Stock, par value $0.001, issued and outstanding 1,182,101 at September 30, 2022 and 1,113,919 shares at December 31, 2021 2,624 2,419
Common stock, $0.001 par value. Authorized, 250,000,000 shares; 92,228,862 and 86,367,845 shares outstanding as of September 30, 2022 and December 31, 2021, respectively 92 86
Additional paid-in capital 214,278 198,071
Accumulated deficit (207,638) (138,910)
Treasury stock (408)
Total PAVmed Inc. Stockholders’ Equity 8,948 61,666
Noncontrolling interests 19,608 17,752
Total Stockholders’ Equity 28,556 79,418
Total Liabilities and Stockholders’ Equity $ 72,465 $ 86,976

Source